{"transactions":[{"id":377267,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-04-02T17:18:20.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":574.212,"price":63.13,"value":36250.00356,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":26998.916,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":574.212},"source":{"system":"sec-edgar","filing":"0000014272-21-000119","document":"wf-form4_161738381347414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000119/wf-form4_161738381347414.xml","form_type":"4"}},{"id":381062,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-02-04T00:17:25.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3054.171,"price":62.21,"value":189999.97791,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":26424.704,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3054.171},"source":{"system":"sec-edgar","filing":"0000014272-21-000049","document":"wf-form4_161239782124115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000049/wf-form4_161239782124115.xml","form_type":"4"}},{"id":382339,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-01-06T01:10:44.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":584.395,"price":62.03,"value":36250.02185,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":23187.894,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":584.395},"source":{"system":"sec-edgar","filing":"0000014272-21-000019","document":"wf-form4_160989542864904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000019/wf-form4_160989542864904.xml","form_type":"4"}},{"id":385264,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-10-02T20:31:38.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":601.261,"price":60.29,"value":36250.02569,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":22433.803,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":601.261},"source":{"system":"sec-edgar","filing":"0000014272-20-000267","document":"wf-form4_160167068073141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000267/wf-form4_160167068073141.xml","form_type":"4"}},{"id":388750,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-07-02T20:57:21.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":616.497,"price":58.8,"value":36250.0236,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":21667.561,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":616.497},"source":{"system":"sec-edgar","filing":"0000014272-20-000212","document":"wf-form4_159372340624194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000212/wf-form4_159372340624194.xml","form_type":"4"}},{"id":392415,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-04-02T20:52:25.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":650.341,"price":55.74,"value":36250.00734,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":20895.03,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":650.341},"source":{"system":"sec-edgar","filing":"0000014272-20-000144","document":"wf-form4_158586072702330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000144/wf-form4_158586072702330.xml","form_type":"4"}},{"id":396233,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-02-04T23:05:18.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":3018.268,"price":62.95,"value":189999.9706,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":20244.689,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3018.268},"source":{"system":"sec-edgar","filing":"0000014272-20-000061","document":"wf-form4_158085750018445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000061/wf-form4_158085750018445.xml","form_type":"4"}},{"id":397510,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-01-03T23:49:07.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":564.73,"price":64.19,"value":36250.0187,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":17105.355,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":564.73},"source":{"system":"sec-edgar","filing":"0000014272-20-000017","document":"wf-form4_157809533063118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000017/wf-form4_157809533063118.xml","form_type":"4"}},{"id":399980,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-10-02T20:51:51.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":714.849,"price":50.71,"value":36249.99279,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":16422.827,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":714.849},"source":{"system":"sec-edgar","filing":"0000014272-19-000176","document":"wf-form4_157004948932454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000176/wf-form4_157004948932454.xml","form_type":"4"}},{"id":401786,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-07-02T21:13:08.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":767.536,"price":45.35,"value":34807.7576,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":15566.776,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":767.536},"source":{"system":"sec-edgar","filing":"0000014272-19-000140","document":"wf-form4_156210197347296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000140/wf-form4_156210197347296.xml","form_type":"4"}},{"id":404683,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-04-02T20:39:20.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":681.199,"price":47.71,"value":32500.00429,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":14670.112,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":681.199},"source":{"system":"sec-edgar","filing":"0000014272-19-000094","document":"wf-form4_155423754602798.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000094/wf-form4_155423754602798.xml","form_type":"4"}},{"id":408403,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-02-05T21:47:01.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":3708.158,"price":49.89,"value":185000.00262,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":13988.913,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3708.158},"source":{"system":"sec-edgar","filing":"0000014272-19-000032","document":"wf-form4_154940320796019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000032/wf-form4_154940320796019.xml","form_type":"4"}},{"id":409535,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-01-03T21:29:56.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":625.24,"price":51.98,"value":32499.9752,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":10064.256,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":625.24},"source":{"system":"sec-edgar","filing":"0000014272-19-000012","document":"wf-form4_154655096964226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000012/wf-form4_154655096964226.xml","form_type":"4"}},{"id":411632,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2018-10-03T01:42:30.000Z","date":"2018-09-30","kind":"grant","acquired":true,"shares":523.518,"price":62.08,"value":32499.99744,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":9439.016,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":523.518},"source":{"system":"sec-edgar","filing":"0000014272-18-000187","document":"wf-form4_153853093272601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427218000187/wf-form4_153853093272601.xml","form_type":"4"}},{"id":413760,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2018-07-04T01:28:48.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":587.279,"price":55.34,"value":32500.01986,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8915.498,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":587.279},"source":{"system":"sec-edgar","filing":"0000014272-18-000152","document":"wf-form4_153066771197420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427218000152/wf-form4_153066771197420.xml","form_type":"4"}},{"id":416270,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2018-04-03T20:36:02.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":513.834,"price":63.25,"value":32500.0005,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8265.47,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":513.834},"source":{"system":"sec-edgar","filing":"0000014272-18-000101","document":"wf-form4_152278772768978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427218000101/wf-form4_152278772768978.xml","form_type":"4"}},{"id":419778,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2018-02-05T23:20:11.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":2945.86,"price":62.8,"value":185000.008,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":7751.636,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":2945.86},"source":{"system":"sec-edgar","filing":"0000014272-18-000044","document":"wf-form4_151787279657237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427218000044/wf-form4_151787279657237.xml","form_type":"4"}},{"id":420994,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2018-01-03T23:33:49.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":530.352,"price":61.28,"value":32499.97056,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":4775.359,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":530.352},"source":{"system":"sec-edgar","filing":"0000014272-18-000020","document":"wf-form4_151502241512490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427218000020/wf-form4_151502241512490.xml","form_type":"4"}},{"id":423218,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2017-10-03T20:50:24.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":509.884,"price":63.74,"value":32500.00616,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."}],"balance_after":4218.54,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":509.884},"source":{"system":"sec-edgar","filing":"0000014272-17-000186","document":"wf-form4_150706381075251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427217000186/wf-form4_150706381075251.xml","form_type":"4"}},{"id":425161,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2017-07-05T22:02:34.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":537.423,"price":55.72,"value":29945.20956,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":3683.031,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":537.423},"source":{"system":"sec-edgar","filing":"0000014272-17-000154","document":"wf-form4_149929212647399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427217000154/wf-form4_149929212647399.xml","form_type":"4"}},{"id":427797,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2017-04-04T23:20:29.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":199.217,"price":54.38,"value":10833.42046,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":3123.971,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":199.217},"source":{"system":"sec-edgar","filing":"0000014272-17-000119","document":"wf-form4_149134801586871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427217000119/wf-form4_149134801586871.xml","form_type":"4"}},{"id":429656,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2017-02-24T00:29:40.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":2924.754,"price":54.78,"value":160218.02412,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents pro rata portion of the 2017 annual Deferred Share Units awards granted to the Company's directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."}],"balance_after":2924.754,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":2924.754},"source":{"system":"sec-edgar","filing":"0000014272-17-000058","document":"wf-form4_148789616778457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427217000058/wf-form4_148789616778457.xml","form_type":"4"}},{"id":486072,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2012-11-20T21:18:53.000Z","date":"2012-11-16","kind":"sale","acquired":false,"shares":10850,"price":41.76,"value":453096.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sales reported on this line occurred at a weighted average price of $41.76 (range $41.63 to $41.95)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":200873,"source":{"system":"sec-edgar","filing":"0001209191-12-054064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112054064/doc4.xml","form_type":"4"}},{"id":490853,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2012-06-01T21:05:22.000Z","date":"2012-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":59.55,"exercise_date":"2012-06-01","expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-12-031706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112031706/doc4.xml","form_type":"4"}},{"id":496398,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2012-02-07T21:29:32.000Z","date":"2011-02-06","kind":"sale","acquired":false,"shares":40600,"price":38.08,"value":1546048.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Emmens' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $38.08 (range $37.70 to $38.33)."}],"balance_after":211601,"source":{"system":"sec-edgar","filing":"0001209191-12-008147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112008147/doc4.xml","form_type":"4"}},{"id":496397,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2012-02-07T21:29:32.000Z","date":"2011-02-06","kind":"sale","acquired":false,"shares":12900,"price":37.11,"value":478719.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Emmens' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $37.11 (range $36.68 to $37.67)."}],"balance_after":252201,"source":{"system":"sec-edgar","filing":"0001209191-12-008147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112008147/doc4.xml","form_type":"4"}},{"id":496396,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2012-02-07T21:29:32.000Z","date":"2011-02-06","kind":"sale","acquired":false,"shares":2500,"price":36.39,"value":90975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Emmens' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $36.39 (range $35.64 to $36.61)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":265101,"source":{"system":"sec-edgar","filing":"0001209191-12-008147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112008147/doc4.xml","form_type":"4"}},{"id":496575,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option","published_at":"2012-02-06T21:04:46.000Z","date":"2012-02-02","kind":"grant","acquired":true,"shares":236000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/02/2012."}],"balance_after":236000,"derivative":{"exercise_price":37.86,"exercise_date":"2012-05-02","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":236000},"source":{"system":"sec-edgar","filing":"0001209191-12-007770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112007770/doc4.xml","form_type":"4"}},{"id":496574,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2012-02-06T21:04:46.000Z","date":"2012-02-02","kind":"grant","acquired":true,"shares":47201,"price":0.01,"value":472.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/2/2016, subject to (i) earlier acceleration of 50% of shares upon (A) reaching specified aggregate product and royalty sales levels or (B) completing enrollment of a pivotal trial in two distinct disease indications other than HCV and cystic fibrosis and (ii) earlier acceleration of 50% of shares upon receiving filing confirmation for an NDA for an all-oral regimen for the treatment of HCV infection."}],"balance_after":267601,"source":{"system":"sec-edgar","filing":"0001209191-12-007770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112007770/doc4.xml","form_type":"4"}},{"id":502512,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option","published_at":"2011-07-14T19:02:38.000Z","date":"2011-07-13","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011."}],"balance_after":118000,"derivative":{"exercise_price":51.75,"exercise_date":"2011-10-13","expiration_date":"2021-07-12","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001209191-11-039504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039504/doc4.xml","form_type":"4"}},{"id":503661,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2011-05-26T19:55:13.000Z","date":"2011-05-25","kind":"sale","acquired":false,"shares":9735,"price":55.51,"value":540389.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sales reported on this line occurred at a weighted average price of $55.51 (range $55.27 to $55.66)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":220400,"source":{"system":"sec-edgar","filing":"0001209191-11-031209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111031209/doc4.xml","form_type":"4"}},{"id":509355,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2011-02-07T19:52:51.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":236000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/03/2011."}],"balance_after":236000,"derivative":{"exercise_price":38.8,"exercise_date":"2011-05-03","expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":236000},"source":{"system":"sec-edgar","filing":"0000875320-11-000008","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000008/edgar.xml","form_type":"4"}},{"id":509354,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2011-02-07T19:52:51.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":47201,"price":0.01,"value":472.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/3/2015, subject to (i) earlier acceleration of 50% of shares upon (A) receiving U.S. and E.U. marketing approval for VX-770 or (B) reaching specified telaprevir sales levels during 18 months following its U.S. launch; and (ii) earlier acceleration of 50% of shares upon  (1) acceptance by the FDA of an NDA for a treatment regimen that includes telaprevir and VX-222; (2) initiation of a pivotal trial for a drug candidate for which the Company has U.S. commercialization rights in an indication that is not HCV infection or CF; or (3) reaching specified telaprevir sales levels during 18 months following its U.S. launch."}],"balance_after":229406,"source":{"system":"sec-edgar","filing":"0000875320-11-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000008/edgar.xml","form_type":"4"}},{"id":516194,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2010-07-16T19:54:47.000Z","date":"2010-07-14","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010."}],"balance_after":118000,"derivative":{"exercise_price":33.82,"exercise_date":"2010-10-14","expiration_date":"2020-07-13","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0000875320-10-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000043/edgar.xml","form_type":"4"}},{"id":523490,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Options","published_at":"2010-02-08T18:45:54.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":354000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock option under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years."}],"balance_after":354000,"derivative":{"exercise_price":39.05,"exercise_date":"2010-05-04","expiration_date":"2020-02-03","underlying":"Common Stock","underlying_shares":354000},"source":{"system":"sec-edgar","filing":"0000875320-10-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000009/edgar.xml","form_type":"4"}},{"id":523489,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2010-02-08T18:45:54.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":47201,"price":0.01,"value":472.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/4/2014, subject to 50% acceleration upon receiving U.S. marketing approval for telaprevir; and to 50% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of any additional drug beyond telaprevir prior to December 31, 2012."}],"balance_after":182205,"source":{"system":"sec-edgar","filing":"0000875320-10-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000009/edgar.xml","form_type":"4"}},{"id":533589,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2009-02-06T21:26:09.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":549000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09."}],"balance_after":549000,"derivative":{"exercise_price":33.55,"exercise_date":"2009-05-05","expiration_date":"2019-02-04","underlying":"Common Stock","underlying_shares":549000},"source":{"system":"sec-edgar","filing":"0000875320-09-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000009/edgar.xml","form_type":"4"}},{"id":533588,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2009-02-06T21:26:09.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":134129,"price":0.01,"value":1341.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2012."}],"balance_after":134129,"source":{"system":"sec-edgar","filing":"0000875320-09-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000009/edgar.xml","form_type":"4"}},{"id":544164,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2008-06-02T20:49:30.000Z","date":"2008-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":28.4,"exercise_date":"2008-06-01","expiration_date":"2018-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-08-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000041/edgar.xml","form_type":"4"}},{"id":578574,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2007-06-04T16:57:13.000Z","date":"2007-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":29.84,"exercise_date":"2007-06-01","expiration_date":"2017-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-07-000066","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000066/edgar.xml","form_type":"4"}},{"id":606678,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2006-06-02T17:31:41.000Z","date":"2006-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":50000,"derivative":{"exercise_price":34.32,"exercise_date":"2006-06-01","expiration_date":"2016-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-06-000053","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000053/edgar.xml","form_type":"4"}},{"id":638723,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15681,"kind":"person","name":"Emmens Matthew","position":1,"cik":"0001298332","reported_name":"Emmens Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2005-06-03T14:56:14.000Z","date":"2005-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan.  Fully vested."}],"balance_after":30000,"derivative":{"exercise_price":13.32,"exercise_date":"2005-06-01","expiration_date":"2015-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-05-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000027/edgar.xml","form_type":"4"}}]}